Author: Feldan

News

Feldan

Feldan

Recent Posts

VIEW ALL

FELDAN THERAPEUTICS APPOINTS DR ROBERT J. WILLS TO BOARD OF DIRECTORS

Quebec City, Canada, June 16, 2020, Feldan Therapeutics, a biotechnology company focusing on the development of therapeutics based on...

June 16, 2020

FELDAN THERAPEUTICS ANNOUNCES A PUBLICATION IN NATURE COMMUNICATIONS

October 28, 2019

FELDAN THERAPEUTICS HONORED AT THE 2019 ANGES QUÉBEC ANNUAL RENDEZ-VOUS

June 14, 2019

AMGEN AND TAKEDA JOIN THE QUANTUM LEAP PROJECT LED BY CQDM AND FELDAN THERAPEUTICS, TO IMPROVE A NOVEL INTRACELLULAR DELIVERY TECHNOLOGY

June 4, 2019

NEW CORPORATE IDENTITY FOR FELDAN THERAPEUTICS

February 8, 2019

FRANCOIS-THOMAS MICHAUD RECIPIENT OF THE VISIONARY ENTREPRENEUR OF THE YEAR AWARD

December 5, 2018

FELDAN THERAPEUTICS ANNOUNCES ADDITIONAL INVESTMENT IN SERIES A

Québec City, Canada, November 27, 2018 – Feldan Therapeutics (hereafter “Feldan”), a preclinical biotechnology company specialized in...

November 27, 2018

UNIVERSITY OF IOWA AND FELDAN THERAPEUTICS AWARDED GRANT BY THE NATIONAL INSTITUTES OF HEALTH

Quebec City, Canada, October 12, 2018 – David Guay, Research Director of Feldan Therapeutics (hereafter “Feldan”) announced that his...

October 12, 2018

FELDAN THERAPEUTICS RAISES $12.5 MILLION IN SERIES A FINANCING ROUND

QUÉBEC CITY, Sept. 18, 2018 /CNW Telbec/ - Feldan Therapeutics (hereafter "Feldan") has announced the closing of a $12.5 millions...

September 18, 2018

GC LABCELL AND FELDAN THERAPEUTICS ANNOUNCE LICENSE AGREEMENT TO DEVELOP NEXT-GENERATION NK CELLS FOR IMMUNOTHERAPY USING FELDAN SHUTTLE TECHNOLOGY

Seoul (South Korea) & Québec City (Canada) June 27, 2018 – GC LabCell (hereafter “GCLC”) and Feldan Therapeutics (hereafter “Feldan”)...

June 27, 2018